AOPA has released a statement saying that rumors that the CMS could extend the competitive bidding program for off-the-shelf orthotics to more than 100 devices have not been confirmed, but that if they do prove to be true, the CMS would be harming Medicare beneficiaries and violating the law. "[T]he sole statutory authority CMS has been granted by Congress relates solely to 'off-the-shelf orthotics,' as that term is defined in the statute — nothing has happened to change that," AOPA said in its statement. The association has prepared a contingency plan, which includes an analysis of competitive bidding and congressional authorization, as well as requests for meetings with officials at the CMS.

Related Summaries